News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Auster Martin
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/07/2023 |
4
| Auster Martin (CFO) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 24,246 shares
@ $34.5945, valued at
$838.8k
Sold 3,754 shares
@ $34.9452, valued at
$131.2k
Exercised 28,000 options to buy
@ $3.45, valued at
$96.6k
|
|
| 06/06/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/27/2023 |
4
| Auster Martin (CFO) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 18,748 shares
@ $37.554, valued at
$704.1k
Sold 4,262 shares
@ $38.7553, valued at
$165.2k
Sold 4,990 shares
@ $39.229, valued at
$195.8k
Exercised 28,000 options to buy
@ $3.45, valued at
$96.6k
|
|
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2023 |
4
| Auster Martin (CFO) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 9,577 shares
@ $30.2431, valued at
$289.6k
Sold 9,535 shares
@ $31.069, valued at
$296.2k
Sold 1,888 shares
@ $31.861, valued at
$60.2k
Exercised 21,000 options to buy
@ $3.45, valued at
$72.5k
|
|
| 01/18/2023 |
4
| Auster Martin (CFO) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Granted 108,750 options to buy
@ $33.84, valued at
$3.7M
Granted 18,125 restricted stock units
@ $0 |
|
| 12/06/2022 |
4
| Auster Martin (CFO) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 97,647 shares
@ $29.0086, valued at
$2.8M
Exercised 50,000 options to buy
@ $3.45, valued at
$172.5k
|
|
| 02/04/2022 |
4
| Auster Martin (CFO) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Granted 145,000 options to buy
@ $12.21, valued at
$1.8M
|
|
| 10/20/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|